IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) (Q34988311)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
scientific article

    Statements

    IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) (English)
    0 references
    0 references
    Joanne L Jones
    Chia-Ling Phuah
    Amanda L Cox
    Sara A Thompson
    Jacqueline Shawcross
    Amie Walton
    Stephen J Sawcer
    Alasdair J Coles
    2052-2061

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit